Please assess the completion status of the following clinical trial:

Trial Title: COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Documented history of hypertension~* Triglycerides of 120-400 mg/mL~* LDLc levels not requiring lipid lowering medication.~Exclusion Criteria:~* Has known contraindication to alpha- or beta-blocker therapy.~* Has taken any non-ocular beta-blockers within three months before screening.~* Has Type I or II diabetes.~* Taking lipid lowering medications.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Carvedilol Phosphate modified release formulation (Type: EXPERIMENTAL): None
- metoprolol succinate (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).